Additionally, in CMT-N7 cells, TNF/MAPK inflammatory pathway-related genes such as CXCL10 and MECOM were significantly upregulated following W6134 and XY018 treatment, exhibiting favorable anti-tumor effects, which aligns with previous findings [25,28]. The gene discussed is MECOM; the disease is neoplasm.